{"id":"W2174132185","doi":"10.1016/s0140-6736(15)00388-8","title":"Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial","year":2015,"lang":"en","type":"article","venue":"The Lancet","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":566,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Eczema Area and Severity Index; Dupilumab; Medicine; Atopic dermatitis; Blinding; Placebo; Dermatology Life Quality Index; Randomized controlled trial; Clinical trial; Internal medicine; Adverse effect; SCORAD; Placebo-controlled study; Clinical endpoint; Dermatology; Double blind; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001697551,0.001568691,0.003094734,0.0002973702,0.0004486052,0.001241402,0.0007544923,0.002351289,0.004083966],"category_scores_gemma":[0.002160679,0.0006730022,0.002505078,0.0003180617,0.001096156,0.001119691,0.0003815385,0.002969239,0.0007352743],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007967311,"about_ca_system_score_gemma":0.0005190903,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008427648,"about_ca_topic_score_gemma":0.001635958,"domain_scores_codex":[0.9992377,0.0003753261,0.00005517445,0.0001505235,0.00005583564,0.000125515],"domain_scores_gemma":[0.9990321,0.0003739579,0.0002101614,0.00007487814,0.00006691575,0.0002419679],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9820721,0.001754512,0.001067795,0.0008029243,0.001240258,0.00005635414,0.00005951951,0.0001297588,0.002060987,0.0000625356,0.0005997937,0.01009352],"study_design_scores_gemma":[0.947511,0.04641811,0.003631485,0.00005782392,0.001052398,0.00007841076,0.0000373646,0.0002227813,0.0003081792,0.0001126439,0.0005521782,0.00001781546],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9845878,0.0110316,0.0002895426,0.0006079708,0.0004808724,0.0009866419,0.000641961,0.00005704119,0.001316654],"genre_scores_gemma":[0.9927321,0.002871318,0.0004551949,0.0009504988,0.0003716796,0.0007139883,0.0006058393,0.00001179129,0.001287574],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004083966,"threshold_uncertainty_score":0.01366222,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01984300005220019,"score_gpt":0.2878115342263952,"score_spread":0.267968534174195,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}